Cells made by fusing a normal human muscle cell with a muscle cell from a person with Duchenne Muscular Dystrophy were able to significantly improve muscle function when implanted into the muscles of a mouse model of the disease.
Chimeric Cells Restore Crucial Protein in Duchenne Muscular Dystrophy
Chimeric Cells Restore Crucial Protein in Duchenne Muscular DystrophyCells made by fusing a normal human muscle cell with a muscle cell from a person with Duchenne Muscular Dystrophy were able to significantly improve muscle function when implanted into the muscles of a mouse model of the disease.
Measuring Gene Activity in Single Cells
Measuring Gene Activity in Single CellsResearchers have developed a new method to classify and track the multitude of cells in a tissue sample.
Stem Cell Transplants Can Treat MS
Stem Cell Transplants Can Treat MSA new clinical trial indicates that stem cell transplants can prevent the progression of MS. The transplants also helped to improve the symptoms of patients.
NGS Based Cancer Tests Covered By Medicare
NGS Based Cancer Tests Covered By MedicareThe Centers for Medicare and Medicaid Services will now cover Medicare diagnostic lab tests that use DNA testing to determine the best treatment for patients with advanced cancer.
BRCA Mutation Carriers: Obesity Linked with Increased DNA Damage
BRCA Mutation Carriers: Obesity Linked with Increased DNA DamageBeing obese or having a higher BMI while carrying a BRCA mutation is positively linked with higher levels of damage to the DNA in normal breast gland cells, new research suggests.
Researchers have developed a new method to classify and track the multitude of cells in a tissue sample.
A new clinical trial indicates that stem cell transplants can prevent the progression of MS. The transplants also helped to improve the symptoms of patients.
The Centers for Medicare and Medicaid Services will now cover Medicare diagnostic lab tests that use DNA testing to determine the best treatment for patients with advanced cancer.
Being obese or having a higher BMI while carrying a BRCA mutation is positively linked with higher levels of damage to the DNA in normal breast gland cells, new research suggests.
UK-based genomics data platform Global Gene Corp and American genetics company, Regeneron Genetics Center announced yesterday that they will collaborate to create the world’s largest project of its kind to study Indian population.
Following on from our feature last week, that discussed the ‘origin of life’, we sat down with George Church, a project supporter, to find hear his thoughts.
As it’s Rare Disease Day, we’ve put together some relevant resources from The American Society of Human Genetics (ASHG) on pediatric testing.
John Wallace explains how an opportunity to take part in a WGS study to diagnose his son gave answer s to an undiagnosed condition his wife had been living with for 40 years.
The Short Read
“How Can We Anticipate and Respond to Technologies and Information That is Rapidly Changing?” – Josephine Johnston
Josephine Johnston is an expert on the ethical, legal and policy implications of biomedical technologies, particularly as used in human reproduction, psychiatry, genetics, and neuroscience.
“I Would Like to See Widespread Reimbursement of Clinical Genomic Testing as Well as Screening” – Gavin Stone
Gavin Stone is an electronics engineer who joined Edico Genome in 2013 to lead corporate development and marketing for the DRAGEN™ Bio-IT Processor, the world’s first next-generation sequencing bioinformatics chip to massively speed up genomic medicine.
“It’s Through Community Outreach & Education We Ensure Continued Public Commitment” – Hsiao-Tuan Chao
Hsiao-Tuan Chao is a physician-scientist in the field of child neurology, we’ve had a chat with her in this week’s Short Read.
Magazines and Educational Guides
In this issue of the magazine, we talk all things ACMG, and speak to some of the most prolific figures in the industry.
Free download: This guide is designed to introduce you to how genomics is being integrated into the clinic, what goes into using a patient’s DNA to reach a diagnosis, and how this information can be communicated to primary care physicians.
We bring genomics to the UK in our latest issue, as we look ahead to what this year’s Festival of Genomics London has to offer.
We surveyed a cross-section of the international genomics workforce to find out which jobs, and where, are typically best paid; whether or not the gender pay gap still exists; what attracts people to their jobs; and where those people are coming from.
What’s blockchain technology, how, and why was it developed, and why is everyone talking about it? Alex Schmid provides us with an overview of challenges blockchain technology can help solve within life sciences, and what about it, that makes it so suitable.
Just as sequencing has been getting faster, so too has library preparation. The process can be broadly broken up into 5-6 main stages, depending on method.
Learn more about Edico Genome’s new DRAGEN Virtual Long-Read Detection (VLRD) Pipeline, that’s the first variant caller dedicated to SDs, and is designed to run with short sequence reads generated at moderate coverage.
With do-it-yourself CRISPR kits now available online, Hannah Devlin asks if it’s really possible to edit your own DNA, is it safe and how should it be regulated?
A discussion of the technology that is in use today that allows Metabolon to carry out n of 1 studies that enable precision medicine, as well as future technology. Available on-demand.
Around the Web
Designed to accelerate pre-clinical genomic research and drug discovery for the benefit of patients, the team behind the global genomic data marketplace has grown by nearly 50% in the past year.
New research shows that a test for measuring the length of DNA endcaps called telomeres can alter treatment decisions for patients with certain types of bone marrow failures.
QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing in second half 2018 in Europe and later in the U.S.
The promise of precision medicine is replacing the one-size-fits-all medicine of the past. Doctors hope this will make everyone healthier. But a new report says certain groups in the US are in jeopardy of being worse off when medicine is tailor-made. Who stands to lose?
This is 2018 guys; people are injecting stem cells into their penises hoping to make them bigger, and having their cheeks swabbed hoping to find the one. What’s going on?
A USD $5 million technology prize aims to crack the origin of the genetic code. The Evolution 2.0 Prize was announced at Arizona State University in August 2017. The largest “origin of life” prize to date, it seeks to bridge the gap between chemistry, genomics and modern computing.